You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 8, August 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Brain Magnetic Resonance Imaging in Acute Optic Neuritis

Experience of the Optic Neuritis Study Group

Roy W. Beck, MD; John Arrington, MD; F. Reed Murtagh, MD; Patricia A. Cleary, MS; David I. Kaufman, DO; Optic Neuritis Study Group

Arch Neurol. 1993;50(8):841-846.


Abstract

• Objective.
—Changes in the brain on magnetic resonance images are common in patients with optic neuritis even when there is no other clinical evidence of multiple sclerosis. The current study was designed to determine systematically the prevalence of brain abnormalities on magnetic resonance images in the patients entered into the Optic Neuritis Treatment Trial.

Design.
—Prospective multicenter clinical trial.

Setting.
—Referral centers.

Patients and Methods.
—Brain magnetic resonance images from 418 patients with acute optic neuritis (77% women; mean age, 32.0 years) were evaluated at a central reading center with the use of a standardized classification system (ranging from 0 for normal to IV for most extensive changes).

Results.
—Of the scans, 40.9% were classified as grade 0, 10.8% as grade I, 9.1% as grade II, 6.7% as grade III, and 32.5% as grade IV. For patients with isolated (monosymptomatic) optic neuritis, 26.7% had two or more lesions.

Conclusions.
—We found a lower prevalence of brain magnetic resonance imaging abnormalities in isolated optic neuritis than previous studies have reported. This likely is due to our study having a higher degree of standardization of patient inclusion criteria, which limited patient selection bias.



Author Affiliations

From the Departments of Ophthalmology (Dr Beck), Neurology (Dr Beck), and Radiology (Drs Arrington and Murtagh), University of South Florida College of Medicine, Tampa; Biostatistics Center, George Washington University, Washington, DC (Ms Cleary); and Department of Neurology, Michigan State University, East Lansing (Dr Kaufman).


Footnotes

Accepted for publication December 8, 1992.

Presented at the meeting of the American Society of Neuroradiology, St Louis, Mo, June 1, 1992.

Reprint requests to Department of Ophthalmology, MDC Box 21, University of South Florida College of Medicine, Tampa, FL 33612 (Dr Beck).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up
The Optic Neuritis Study Group
Arch Neurol 2008;65:727-732.
ABSTRACT | FULL TEXT  

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
Koch et al.
Neurology 2007;68:1163-1164.
FULL TEXT  

Clinical practice. Optic neuritis.
Balcer
NEJM 2006;354:1273-1280.
FULL TEXT  

Long-term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Optic Neuritis Study Group
Arch Neurol 2004;61:1538-1541.
ABSTRACT | FULL TEXT  

Neurologic Impairment 10 Years After Optic Neuritis
Optic Neuritis Study Group
Arch Neurol 2004;61:1386-1389.
ABSTRACT | FULL TEXT  

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial
Optic Neuritis Study Group*
Arch Ophthalmol 2003;121:944-949.
ABSTRACT | FULL TEXT  

Short-term prognosis in early relapsing-remitting multiple sclerosis
Scott et al.
Neurology 2000;55:689-693.
ABSTRACT | FULL TEXT  

To Treat, or Not to Treat: The Therapeutic Dilemma of Idiopathic Monosymptomatic Demyelinating Syndromes
Frohman et al.
Arch Neurol 2000;57:930-932.
FULL TEXT  

Prognostic Value of MR and Magnetization Transfer Imaging Findings in Patients withClinically Isolated Syndromes Suggestive ofMultiple Sclerosis at Presentation
Iannucci et al.
Am. J. Neuroradiol. 2000;21:1034-1038.
ABSTRACT | FULL TEXT  

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS
Hauser et al.
Neurology 2000;54:1859-1861.
ABSTRACT | FULL TEXT  

Multisequence MRI in clinically isolated syndromes and the early development of MS
Brex et al.
Neurology 1999;53:1184-1184.
ABSTRACT | FULL TEXT  

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
Fazekas et al.
Neurology 1999;53:448-448.
ABSTRACT | FULL TEXT  

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
Sailer et al.
Neurology 1999;52:599-599.
ABSTRACT | FULL TEXT  

The Optic Neuritis Treatment Trial: Three-Year Follow-up Results
Beck and Optic Neuritis Study Group
Arch Ophthalmol 1995;113:136-137.
ABSTRACT  

Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial
Keltner et al.
Arch Ophthalmol 1994;112:946-953.
ABSTRACT  

The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis
Beck et al.
NEJM 1993;329:1764-1769.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.